GLP-1 Receptor Agonists Versus Empagliflozin or Dapagliflozin in the MASLD-Heart Failure Phenotype: An Exploratory Propensity-Matched Cohort Study
- DOI
- 10.4274/balkanmedj.galenos.2026.2026-7-49
- Published
- 2026-11-02
- Container
- Balkan Medical Journal
- Publisher
- Galenos Yayinevi
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.4274/balkanmedj.galenos.2026.2026-7-49,
title = {GLP-1 Receptor Agonists Versus Empagliflozin or Dapagliflozin in the MASLD-Heart Failure Phenotype: An Exploratory Propensity-Matched Cohort Study},
author = {Naveen Gautam and Tien Manh Huynh and Hong Hieu Truong and Nikki Duong},
year = {2026},
journal = {Balkan Medical Journal},
doi = {10.4274/balkanmedj.galenos.2026.2026-7-49},
url = {https://doi.org/10.4274/balkanmedj.galenos.2026.2026-7-49}
}RIS
TY - JOUR TI - GLP-1 Receptor Agonists Versus Empagliflozin or Dapagliflozin in the MASLD-Heart Failure Phenotype: An Exploratory Propensity-Matched Cohort Study AU - Naveen Gautam AU - Tien Manh Huynh AU - Hong Hieu Truong AU - Nikki Duong PY - 2026 JO - Balkan Medical Journal DO - 10.4274/balkanmedj.galenos.2026.2026-7-49 UR - https://doi.org/10.4274/balkanmedj.galenos.2026.2026-7-49 ER -
APA
Gautam, N., Huynh, T. M., Truong, H. H., & Duong, N. (2026). GLP-1 Receptor Agonists Versus Empagliflozin or Dapagliflozin in the MASLD-Heart Failure Phenotype: An Exploratory Propensity-Matched Cohort Study. Balkan Medical Journal. https://doi.org/10.4274/balkanmedj.galenos.2026.2026-7-49
Source records
- crossref · retrieved 2026-11-07T05:41:58.353Z